These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36766268)

  • 41. GnRH-agonist implantation of prepubertal male cats affects their reproductive performance and testicular LH receptor and FSH receptor expression.
    Mehl NS; Khalid M; Srisuwatanasagul S; Swangchan-Uthai T; Sirivaidyapong S
    Theriogenology; 2016 Mar; 85(5):841-848. PubMed ID: 26620725
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [GnRH agonist implants in small animal practice - what do we know 13 years following EU registration?].
    Stempel S; Goericke-Pesch S
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2020 Dec; 48(6):420-432. PubMed ID: 33276392
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical use of Anti-Müllerian Hormone to monitor resumption of ovarian activity following removal of a 4.7 mg deslorelin implant in queens.
    Ferré-Dolcet L; Ferro S; Contiero B; Fontaine C; Badon T; Gelli D; Romagnoli S
    Vet Res Commun; 2022 Sep; 46(3):917-924. PubMed ID: 35347540
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term effects of GnRH agonists on fertility and behaviour.
    Goericke-Pesch S
    Reprod Domest Anim; 2017 Apr; 52 Suppl 2():336-347. PubMed ID: 28025851
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Resumption of ovarian activity following removal of a 4.7 mg deslorelin implant in queens.
    Ferré-Dolcet L; Ferro S; Contiero B; Andretta F; Cattai A; Fontaine C; Romagnoli S
    Reprod Domest Anim; 2022 Jan; 57(1):3-9. PubMed ID: 34610192
    [TBL] [Abstract][Full Text] [Related]  

  • 47. What Happens in Male Dogs after Treatment with a 4.7 mg Deslorelin Implant? II. Recovery of Testicular Function after Implant Removal.
    Stempel S; Körber H; Reifarth L; Schuler G; Goericke-Pesch S
    Animals (Basel); 2022 Sep; 12(19):. PubMed ID: 36230286
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Investigation of the efficacy of the GnRH agonist deslorelin in mitigating intraspecific aggression in captive male Amur leopards (Panthera pardus orientalis).
    Harley JJ; Power A; Stack JD
    Zoo Biol; 2019 Mar; 38(2):214-219. PubMed ID: 30653720
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ovarian activity reversibility after the use of deslorelin acetate as a short-term contraceptive in domestic queens.
    Ackermann CL; Volpato R; Destro FC; Trevisol E; Sousa NR; Guaitolini CR; Derussi AA; Rascado TS; Lopes MD
    Theriogenology; 2012 Sep; 78(4):817-22. PubMed ID: 22578612
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effects of a slow release GnRH agonist implant on male rabbits.
    Goericke-Pesch S; Groeger G; Wehrend A
    Anim Reprod Sci; 2015 Jan; 152():83-9. PubMed ID: 25466212
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epididymectomy as a novel surgical procedure; application in the domestic cat.
    Furthner E; Fabian R; Kipar A; Schuler G; Janett F; Nudelmann N; Kutter APN; Reichler IM
    Theriogenology; 2023 Apr; 200():168-178. PubMed ID: 36806926
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical and endocrine responses to treatment with deslorelin acetate implants in ferrets with adrenocortical disease.
    Wagner RA; Piché CA; Jöchle W; Oliver JW
    Am J Vet Res; 2005 May; 66(5):910-4. PubMed ID: 15934621
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Changes in testicular steroidogenic acute regulatory (STAR) protein, steroidogenic enzymes and testicular morphology associated with increased testosterone secretion in bulls receiving the luteinizing hormone releasing hormone agonist deslorelin.
    Aspden WJ; Rodgers RJ; Stocco DM; Scott PT; Wreford NG; Trigg TE; Walsh J; D'Occhio MJ
    Domest Anim Endocrinol; 1998 Jul; 15(4):227-38. PubMed ID: 9673455
    [TBL] [Abstract][Full Text] [Related]  

  • 54. DESLORELIN (SUPRELORIN
    Agnew MK; Asa CS; Franklin AD; McDonald MM; Cowl VB
    J Zoo Wildl Med; 2021 Jun; 52(2):427-436. PubMed ID: 34130384
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Variable duration of reproductive suppression in male coyotes (Canis latrans) treated with a high dose of the gonadotrophin-releasing hormone agonist deslorelin.
    MacGregor MJ; Asa CS; Skinner DC
    Reprod Fertil Dev; 2017 Jul; 29(7):1271-1279. PubMed ID: 27161891
    [TBL] [Abstract][Full Text] [Related]  

  • 56. COMPARISON OF TWO 4.7-MILLIGRAM TO ONE 9.4-MILLIGRAM DESLORELIN ACETATE IMPLANTS ON EGG PRODUCTION AND PLASMA PROGESTERONE CONCENTRATIONS IN JAPANESE QUAIL (COTURNIX COTURNIX JAPONICA).
    Petritz OA; Guzman DS; Hawkins MG; Kass PH; Conley AJ; Paul-Murphy J
    J Zoo Wildl Med; 2015 Dec; 46(4):789-97. PubMed ID: 26667535
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term-release GnRH agonists postpone puberty in domestic cats.
    Risso A; Corrada Y; Barbeito C; Diaz JD; Gobello C
    Reprod Domest Anim; 2012 Dec; 47(6):936-8. PubMed ID: 22335549
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of a deslorelin implant for influencing sex hormones and male behaviour in a stallion - Case report.
    Schönert S; Reher M; Gruber AD; Carstanjen B
    Acta Vet Hung; 2012 Dec; 60(4):511-9. PubMed ID: 23160033
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Delay of puberty and reproductive performance in male dogs following the implantation of 4.7 and 9.4 mg GnRH-agonist deslorelin at an early pre-pubertal age.
    Sirivaidyapong S; Mehl NS; Trigg TE
    Reprod Domest Anim; 2012 Dec; 47 Suppl 6():400-2. PubMed ID: 23279549
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Removal of deslorelin (Ovuplant) implant 48 h after administration results in normal interovulatory intervals in mares.
    McCue PM; Farquhar VJ; Carnevale EM; Squires EL
    Theriogenology; 2002 Sep; 58(5):865-70. PubMed ID: 12212887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.